Urica Therapeutics
BiotechnologyMiami, FL
Total funding$2.5M#29 of 32 in Biotechnology
Founded2021
SectorBiotechnology
HQMiami
About
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases. Urica is a subsidiary company of Fortress Biotech.
Urica Therapeutics is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.
Similar companies
View allASP IsotopesBiotechnology | Est. 2021 | MIA | $372M |
SyncromuneBiotechnology | Est. 2020 | MIA | $155M |
Pasithea TherapeuticsBiotechnology | Est. 2020 | MIA | $104M |
Myosin TherapeuticsBiotechnology | Est. 2020 | MIA | $15M |
WeoBiotechnology | Est. 2017 | MIA | $10M |
Details
- Region
- South Florida / Miami
- City
- Miami
- Founded
- 2021
- Sector
- Biotechnology
- Website
- uricatherapeutics.com
South Florida / Miami
South Florida anchors the state's fintech, crypto, and Latin America-facing economy, with a deep bilingual talent pool across Miami, Fort Lauderdale, and Palm Beach.
662companies
$21.0Braised